PubRank

Miguel Angel Martínez

Author PubWeight™ 38.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. Hepatology 2007 2.14
2 Unfinished stories on viral quasispecies and Darwinian views of evolution. J Mol Biol 2010 2.00
3 [Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery]. Arch Bronconeumol 2008 1.75
4 HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. Virus Res 2008 1.70
5 Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One 2012 1.48
6 IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients. PLoS One 2010 1.17
7 Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J Virol 2006 1.12
8 HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 2006 1.10
9 Fitness landscape of human immunodeficiency virus type 1 protease quasispecies. J Virol 2006 1.06
10 Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients. PLoS One 2012 1.05
11 Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches. AIDS 2004 1.01
12 Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215. Virology 2004 0.99
13 Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers. J Biol Chem 2004 0.96
14 Epistasis among deleterious mutations in the HIV-1 protease. J Mol Biol 2009 0.96
15 Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region. J Virol 2007 0.95
16 Assessing the use of the "opening angle method" to enforce residual stresses in patient-specific arteries. Ann Biomed Eng 2007 0.95
17 Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection. Virology 2005 0.92
18 Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1. Virus Res 2006 0.90
19 Effect of the size and location of osteochondral defects in degenerative arthritis. A finite element simulation. Comput Biol Med 2006 0.90
20 Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine. J Mol Biol 2006 0.89
21 Risk factors of emergency care and admissions in COPD patients with high consumption of health resources. Respir Med 2004 0.89
22 Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions. Virology 2002 0.86
23 RNA interference as a tool for exploring HIV-1 robustness. J Mol Biol 2011 0.85
24 A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. Virus Res 2007 0.84
25 Spontaneous improvement of the renal function in a patient with HIV-associated focal glomerulosclerosis. Am J Nephrol 2002 0.82
26 Inhibition of HIV-1 replication by RNA targeted against the LTR region. AIDS 2005 0.82
27 Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination. J Biol Chem 2009 0.82
28 Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients. J Virol 2011 0.80
29 HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32. Immunobiology 2012 0.80
30 Level of awareness of personnel in hospital services related to the donation process: A Spanish and Latin American multicenter study. J Heart Lung Transplant 2012 0.80
31 Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses. J Gen Virol 2006 0.79
32 High-throughput, functional screening of the anti-HIV-1 humoral response by an enzymatic nanosensor. Mol Immunol 2006 0.79
33 Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness. J Gen Virol 2012 0.79
34 Antiretroviral therapy-induced functional modification of IgG4 and IgM responses in HIV-1-infected individuals screened by an allosteric biosensor. J Biomol Screen 2008 0.77
35 Inhibition of HIV-1 replication by an improved hairpin ribozyme that includes an RNA decoy. RNA Biol 2005 0.77
36 The Presence of Pretransplant Antiphospholipid Antibodies IgA Anti-β-2-Glycoprotein I as a Predictor of Graft Thrombosis After Renal Transplantation. Transplantation 2017 0.77
37 Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission. J Gen Virol 2003 0.76
38 Engineering the E. coli beta-galactosidase for the screening of antiviral protease inhibitors. Biochem Biophys Res Commun 2005 0.76
39 Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates. Virology 2013 0.76
40 Primary pulmonary lymphoma: diagnosis and follow-up of 6 cases and review of an uncommon entity. Tumori 2005 0.76
41 Analysis of recombinant protein toxicity in E. coli through a phage lambda-based genetic screening system. Biotechnol Lett 2007 0.75
42 [Removal of retrievable inferior vena cava filters 90 days after implantation in an ovine model: is there a time limit for removal?]. Arch Bronconeumol 2008 0.75
43 [Meeting Report: 20 years after the First International Symposium on hepatitis C virus and related viruses]. Gastroenterol Hepatol 2013 0.75
44 The attitude toward living kidney donation among personnel from units related to donation and transplantation in Spain, Mexico and Cuba. Ren Fail 2014 0.75
45 [Frequent, acute episodes of normocytic anemia in a patient with AIDS]. Enferm Infecc Microbiol Clin 2002 0.75
46 Knowledge of the brain death concept by personnel in Spanish and Latin-American healthcare centers. Int J Artif Organs 2014 0.75
47 A theoretical and experimental evaluation of imidazolium-based ionic liquids for atmospheric mercury capture. J Mol Model 2014 0.75
48 Malignant hypertension in HIV-associated glomerulonephritis. Nephrol Dial Transplant 2008 0.75